Stefan Stutz

1.5k total citations
19 papers, 753 citations indexed

About

Stefan Stutz is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Stefan Stutz has authored 19 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Stefan Stutz's work include Receptor Mechanisms and Signaling (8 papers), Cancer-related Molecular Pathways (8 papers) and Chemical Synthesis and Analysis (4 papers). Stefan Stutz is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Cancer-related Molecular Pathways (8 papers) and Chemical Synthesis and Analysis (4 papers). Stefan Stutz collaborates with scholars based in Switzerland, Australia and United States. Stefan Stutz's co-authors include Jürgen Maibaum, Richard Göschke, Walter Fuhrer, Frédéric Cumin, Joseph Rahuel, H. Rüeger, Vittorio Rasetti, M.G. Grütter, J M Wood and Philipp Holzer and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Stefan Stutz

19 papers receiving 721 citations

Peers

Countries citing papers authored by Stefan Stutz

Since Specialization

Citations

This map shows the geographic impact of Stefan Stutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Stutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Stutz more than expected).

Fields of papers citing papers by Stefan Stutz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Stutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Stutz. The network helps show where Stefan Stutz may publish in the future.

Co-authorship network of co-authors of Stefan Stutz

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Stutz. A scholar is included among the top collaborators of Stefan Stutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Stutz. Stefan Stutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Structural States of Hdm2 and HdmX: X‐ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes 2019 ·ChemMedChem ·Joerg Kallen, (unknown), (unknown), (unknown), Joseph Schoepfer, Robert Mah, Achim Schlapbach, Stefan Stutz, Andrea Vaupel, Vito Guagnano, Keiichi Masuya, Therese‐Marie Stachyra, Bahaâ Salem, Patrick Chêne, F. Gessier, Philipp Holzer, Pascal Furet	21
2	In vitro and in vivo characterization of a novel, highly potent p53-MDM2 inhibitor 2018 ·Bioorganic & Medicinal Chemistry Letters ·Andrea Vaupel, Philipp Holzer, Stéphane Ferretti, Vito Guagnano, Joerg Kallen, Robert Mah, Keiichi Masuya, Stephan Ruetz, Caroline Rynn, Achim Schlapbach, Therese‐Marie Stachyra, Stefan Stutz, Milen Todorov, Sébastien Jeay, Pascal Furet	16
3	Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Robin A. Fairhurst, Thomas H. Marsilje, Stefan Stutz, (unknown), (unknown), Bei Chen, Songchun Jiang, Wenshuo Lu, Pascal Furet, Clive McCarthy, Frédéric Stauffer, Vito Guagnano, Andrea Vaupel, Pierre‐Yves Michellys, Christian Schnell, Sébastien Jeay	7
4	Discovery of a novel class of highly potent inhibitors of the p53–MDM2 interaction by structure-based design starting from a conformational argument 2016 ·Bioorganic & Medicinal Chemistry Letters ·Pascal Furet, Keiichi Masuya, Joerg Kallen, Therese‐Marie Stachyra, Stephan Ruetz, Vito Guagnano, Philipp Holzer, Robert Mah, Stefan Stutz, Andrea Vaupel, Patrick Chêne, Sébastien Jeay, Achim Schlapbach	60
5	Abstract 1239: NVP-HDM201: Biochemical and biophysical profile of a novel highly potent and selective PPI inhibitor of p53-Mdm2 2016 ·Cancer Research ·Therese‐Marie Stachyra, (unknown), (unknown), Dirk Erdmann, Pascal Furet, Vito Guagnano, Joerg Kallen, Lukas Leder, Robert Mah, Keiichi Masuya, Stefan Stutz, Andrea Vaupel, Francesco Hofmann, Patrick Chêne, Sébastien Jeay, Philipp Holzer	12
6	Abstract 4855: Discovery of NVP-HDM201 - First disclosure of a Next-Generation Mdm2 inhibitor with superior characteristics 2016 ·Cancer Research ·Philipp Holzer, Patrick Chêne, Stéphane Ferretti, Pascal Furet, Tobias Gabriel, (unknown), Vito Guagnano, Francesco Hofmann, Joerg Kallen, Robert Mah, Keiichi Masuya, (unknown), Stephan Ruetz, Caroline Rynn, Therese‐Marie Stachyra, Stefan Stutz, Andrea Vaupel, Sébastien Jeay	6
7	Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors 2015 ·Journal of Medicinal Chemistry ·Philipp Holzer, Keiichi Masuya, Pascal Furet, Joerg Kallen, Therese‐Marie Stachyra, Stéphane Ferretti, Joerg Berghausen, (unknown), Nicole Buschmann, Carole Pissot‐Soldermann, Caroline Rynn, Stephan Ruetz, Stefan Stutz, Patrick Chêne, Sébastien Jeay, F. Gessier	152
8	Abstract DDT01-01: Discovery of CGM097 as a novel Mdm2 inhibitor 2014 ·Cancer Research ·Keiichi Masuya, Pascal Furet, Stefan Stutz, Philipp Holzer, (unknown), Nicole Buschmann, (unknown), Stéphane Ferretti, Stephan Ruetz, Caroline Rynn, Joerg Berghausen, Edgar Jacoby, Marc Lang, Tobias Gabriel, Francesco Hofmann, Joerg Kallen, Sébastien Jeay, F. Gessier	2
9	Abstract 1798: Mechanistic study of NVP-CGM097: a potent, selective and species specific inhibitor of p53-Mdm2 2014 ·Cancer Research ·(unknown), Keiichi Masuya, (unknown), (unknown), Nicole Buschmann, Dirk Erdmann, Pascal Furet, Tobias Gabriel, F. Gessier, Francesco Hofmann, Philipp Holzer, Joerg Kallen, (unknown), Stefan Stutz, Patrick Chêne, Sébastien Jeay	6
10	Structural Modification of the P2‘ Position of 2,7-Dialkyl-Substituted 5( S )-Amino-4( S )-hydroxy-8-phenyl-octanecarboxamides: The Discovery of Aliskiren, a Potent Nonpeptide Human Renin Inhibitor Active after Once Daily Dosing in Marmosets 2007 ·Journal of Medicinal Chemistry ·Jürgen Maibaum, Stefan Stutz, Richard Göschke, Pascal Rigollier, Yasuchika Yamaguchi, Frédéric Cumin, Joseph Rahuel, (unknown), (unknown), Christian Schnell, Walter Fuhrer, M.G. Gruetter, Walter Schilling, Jeanette M. Wood	67
11	Novel 2,7-Dialkyl-Substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamide Transition State Peptidomimetics Are Potent and Orally Active Inhibitors of Human Renin 2007 ·Journal of Medicinal Chemistry ·Richard Göschke, Stefan Stutz, Vittorio Rasetti, (unknown), Joseph Rahuel, Pascal Rigollier, (unknown), (unknown), Christian Schnell, Trixie Wagner, M.G. Gruetter, Walter Fuhrer, Walter Schilling, Frédéric Cumin, Jeanette M. Wood, Jürgen Maibaum	34
12	The Nonchiral Bislactim Diethoxy Ether as a Highly Stereo‐Inducing Synthon for Sterically Hindered, γ‐Branched α‐Amino Acids: A Practical, Large‐Scale Route to an Intermediate of the Novel Renin Inhibitor Aliskiren. 2003 ·ChemInform ·(unknown), Stefan Stutz, (unknown), (unknown)	2
13	The Nonchiral Bislactim Diethoxy Ether as a Highly Stereo‐Inducing Synthon for Sterically Hindered, γ‐Branched α‐Amino Acids: A Practical, Large‐Scale Route to an Intermediate of the Novel Renin Inhibitor Aliskiren 2003 ·Helvetica Chimica Acta ·Richard Göschke, Stefan Stutz, (unknown), Jürgen Maibaum	22
14	Biphenyl derivatives as novel dual NK1/NK2-receptor antagonists 2002 ·Bioorganic & Medicinal Chemistry Letters ·Robert Mah, Marc Gerspacher, (unknown), Stefan Stutz, Vincenzo Tschinke, Gary P. Anderson, Claude Bertrand, N. Subramanian, Howard Ball	8
15	ChemInform Abstract: A Convergent Synthesis Approach Towards CGP60536B, a Non‐Peptide Orally Potent Renin Inhibitor, via an Enantiomerically Pure Ketolactone Intermediate. 2001 ·ChemInform ·Heinrich Rueeger, Stefan Stutz, (unknown), Felix Spindler, (unknown)	1
16	Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin 2000 ·Chemistry & Biology ·Joseph Rahuel, Vittorio Rasetti, Jürgen Maibaum, H. Rüeger, Richard Göschke, (unknown), Stefan Stutz, Frédéric Cumin, Walter Fuhrer, J M Wood, M.G. Grütter	240
17	A convergent synthesis approach towards CGP60536B, a non-peptide orally potent renin inhibitor, via an enantiomerically pure ketolactone intermediate 2000 ·Tetrahedron Letters ·H. Rüeger, Stefan Stutz, Richard Göschke, Felix Spindler, Jürgen Maibaum	32
18	5-Methyl-6-phenyl-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazocine-2,4- dione (BA 41899): Representative of a Novel Class of Purely Calcium-Sensitizing Agents 1995 ·Journal of Medicinal Chemistry ·Peter Herold, J. W. Herzig, (unknown), (unknown), (unknown), Walter Fuhrer, Stefan Stutz, (unknown), Max Meier, G. Rihs	36
19	Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives 1991 ·Journal of Medicinal Chemistry ·Peter Bühlmayer, Leoluca Criscione, Walter Fuhrer, Pascal Furet, Marc de Gasparo, Stefan Stutz, Steven Whitebread	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact